Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds
Article first published online: 5 JUN 2013
Copyright © 2013 EMBO Molecular Medicine
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
EMBO Molecular Medicine
Volume 5, Issue 7, pages 1103–1118, July 2013
How to Cite
Cherry, J. J., Osman, E. Y., Evans, M. C., Choi, S., Xing, X., Cuny, G. D., Glicksman, M. A., Lorson, C. L. and Androphy, E. J. (2013), Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds. EMBO Mol Med, 5: 1103–1118. doi: 10.1002/emmm.201202305
- Issue published online: 3 JUL 2013
- Article first published online: 5 JUN 2013
- Manuscript Accepted: 2 APR 2013
- Manuscript Revised: 27 MAR 2013
- Manuscript Received: 29 NOV 2012
- NINDS. Grant Number: R21NS064349
- NICHD. Grant Number: R21HD57402
- NICHD. Grant Number: R01HD064850
- Harvard NeuroDiscovery Center
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
|emmm201202305.reviewer_comments.pdf||PDF document||656K||Review Process File|
Figure S1. Schematic of reporter mini-genes.
Figure S2. Weights of treated and control animals.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.